Published in Cold Spring Harb Symp Quant Biol on January 01, 1978
Architecture of metaphase chromosomes and chromosome scaffolds. J Cell Biol (1983) 2.61
A three-dimensional approach to mitotic chromosome structure: evidence for a complex hierarchical organization. J Cell Biol (1987) 2.26
Bacterial genome sizes determined by DNA renaturation studies. J Gen Microbiol (1970) 5.86
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res (1997) 2.98
Genome size of mycoplasmal DNA. Nature (1969) 2.86
Nonsense suppressors of Saccharomyces cerevisiae can be generated by mutation of the tyrosine tRNA anticodon. Nature (1976) 2.07
Biosynthesis of the beta and beta' subunits of RNA polymerase in Escherichia coli. J Mol Biol (1973) 2.03
Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer (1976) 1.97
Replication of the F'lac sex factor in the cell cycle of Escherichia coli. Mol Gen Genet (1971) 1.92
Circular, repetitive DNA in yeast. Biochim Biophys Acta (1972) 1.88
Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. Biochemistry (1982) 1.85
Homologous subfamilies of human alphoid repetitive DNA on different nucleolus organizing chromosomes. Proc Natl Acad Sci U S A (1987) 1.69
Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene (1999) 1.59
The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res (1996) 1.55
Chromosome-specific subfamilies within human alphoid repetitive DNA. J Mol Biol (1986) 1.54
Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1). J Natl Cancer Inst (1980) 1.53
Circular DNA molecules controlling synthesis and transfer of the surface antigen (K88) in Escherichia coli. J Gen Microbiol (1972) 1.41
Inducibility of the Epstein-Barr virus (EBV) cycle and surface marker properties of EBV-negative lymphoma lines and their in vitro EBV-converted sublines. Int J Cancer (1976) 1.41
Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood (1998) 1.41
Higher-order structure of human mitotic chromosomes. Proc Natl Acad Sci U S A (1977) 1.38
Isolation of novel HLA-DR restricted potential tumor-associated antigens from the melanoma cell line FM3. Cancer Res (1997) 1.38
A subfamily of alphoid repetitive DNA shared by the NOR-bearing human chromosomes 14 and 22. Genomics (1988) 1.33
Identification of an Epstein-Barr virus-coded thymidine kinase. EMBO J (1986) 1.31
Alterations of the MMAC1/PTEN gene in lymphoid malignancies. Blood (1998) 1.27
Accumulation of identical T cells in melanoma and vitiligo-like leukoderma. J Invest Dermatol (1999) 1.24
Characterization of a human ovarian teratocarcinoma-derived cell line. Int J Cancer (1980) 1.19
Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL. J Immunol (1999) 1.19
Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectin. J Biol Chem (1985) 1.15
Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells. Cancer Immunol Immunother (1998) 1.15
Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc Natl Acad Sci U S A (1996) 1.14
Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies. J Invest Dermatol (2000) 1.12
DNA base composition of human T strain mycoplasmas. Nature (1968) 1.10
Deoxyribonucleic acid homology in yeasts. Genetic relatedness within the genus Candida. J Gen Microbiol (1969) 1.10
Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Hum Mutat (1997) 1.09
Transformation induced by Epstein-Barr virus and the role of the nuclear antigen. Cold Spring Harb Symp Quant Biol (1980) 1.08
HLA antigen expression at the single cell level on a K562 X B cell hybrid: an analysis with monoclonal antibodies using bacterial binding assays. Somatic Cell Genet (1982) 1.06
Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J Exp Med (1999) 1.05
Inactive proenzyme to tissue-type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. EMBO J (1984) 1.03
Extrachromosomal deoxyribonucleic acid in different enterobacteria. J Bacteriol (1973) 1.02
Heterogeneity of mitochondrial DNA from Saccharomyces carlsbergensis: renaturation and sedimentation studies. J Mol Biol (1974) 1.01
Two-site time-resolved immunofluorometric assay of human insulin. Clin Chem (1986) 1.01
Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas. FEBS Lett (1998) 1.01
In situ T cells in melanoma. Cancer Immunol Immunother (1999) 1.01
Evolutionarily different alphoid repeat DNA on homologous chromosomes in human and chimpanzee. Proc Natl Acad Sci U S A (1992) 1.00
Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules. Tissue Antigens (2000) 1.00
Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one-step affinity purification. EMBO J (1983) 0.99
Repetitive DNA in yeasts. Nat New Biol (1971) 0.99
Expression of basic fibroblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients. Melanoma Res (1999) 0.98
Detection and characterization of alpha-beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE). Biotechniques (1998) 0.97
Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme. Proc Natl Acad Sci U S A (1982) 0.97
Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient. Cancer Immunol Immunother (2001) 0.96
Higher rate of evolution of X chromosome alpha-repeat DNA in human than in the great apes. EMBO J (1992) 0.96
In situ T cell responses against melanoma comprise high numbers of locally expanded T cell clonotypes. J Immunol (1999) 0.96
Somatic cell hybrids between human lymphoma lines. III. Surface markers. Int J Cancer (1977) 0.96
Enzyme-linked immunosorbent assay for human urokinase-type plasminogen activator and its proenzyme using a combination of monoclonal and polyclonal antibodies. J Immunoassay (1986) 0.96
The V410I (G1228A) variant of the caspase-10 gene is a common polymorphism of the Danish population. Blood (2000) 0.95
Monoclonal antibodies to K88ab, K88ac and K88ad fimbriae from enterotoxigenic Escherichia coli. Microb Pathog (1986) 0.95
Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients. Cancer Res (1988) 0.95
Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanoma. J Clin Invest (1996) 0.94
Different subfamilies of alphoid repetitive DNA are present on the human and chimpanzee homologous chromosomes 21 and 22. EMBO J (1987) 0.94
Extrachromosomal deoxyribonucleic acid in R factor-harboring Enterobacteriaceae. J Bacteriol (1976) 0.93
Changing patterns of plasmid-mediated drug resistance during tetracycline therapy. Antimicrob Agents Chemother (1977) 0.92
Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity. Exp Cell Res (2000) 0.92
Activation of preexisting T cell clones by targeted interleukin 2 therapy. Proc Natl Acad Sci U S A (1998) 0.92
Regulation of B lymphocyte replication and maturation. J Cell Biochem (1982) 0.92
Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid. Int J Cancer (1978) 0.91
DNA base composition in mycoplasma, bacteria and yeast. Curr Top Microbiol Immunol (1973) 0.91
Pattern of replication of a colicin factor during the cell cycle of Escherichia coli. J Bacteriol (1972) 0.91
Aberrant p27Kip1 promoter methylation in malignant melanoma. Oncogene (2000) 0.91
Melanoma-associated antigens recognized by cytotoxic T lymphocytes. APMIS (1998) 0.90
Plasminogen activating enzyme in cultured glioblastoma cells. An immunofluorescence study with monoclonal antibody. J Histochem Cytochem (1982) 0.90
Reactivation of chick erythrocyte nuclei after fusion with enucleated cells. Somatic Cell Genet (1975) 0.89
Epstein-Barr virus (EBV), lymphocytes and transformation. J Cancer Res Clin Oncol (1983) 0.89
Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines. Int J Cancer (1997) 0.89
The selection of somatic cell hybrids between human lymphoma cell lines. Somatic Cell Genet (1976) 0.89
Somatic cell hybrids between human lymphoma lines. II. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle. Int J Cancer (1976) 0.89
Evolution of DNA base compositions in microorganisms. Science (1972) 0.88
Escape from host-antitumor immunity. Crit Rev Oncog (1997) 0.88
Transferable and non-transferable drug resistance in enteric bacteria from hospital and from general practice. Scand J Infect Dis (1976) 0.87
An assay for peptide binding to HLA-Cw*0102. Tissue Antigens (1999) 0.87
Mitochondrial DNA and glucose repression in yeast. Biochem Biophys Res Commun (1972) 0.87
Transfection of glioma cells with the neural-cell adhesion molecule NCAM: effect on glioma-cell invasion and growth in vivo. Int J Cancer (1994) 0.86
A one-step DGGE scanning method for detection of mutations in the K-, N-, and H-ras oncogenes: mutations at codons 12, 13 and 61 are rare in B-cell non-Hodgkin's lymphoma. Int J Cancer (1997) 0.86
Expression of immunoglobulin synthesis in human myeloma x non-lymphoid cell heterokaryons: evidence for negative control. Cell Differ (1976) 0.86
Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas. Int J Cancer (1994) 0.86
Assembly of the T-cell antigen receptor. Participation of the CD3 omega chain. J Immunol (1993) 0.85
Cytotoxic T-lymphocyte clones, established by stimulation with the HLA-A2 binding p5365-73 wild type peptide loaded on dendritic cells In vitro, specifically recognize and lyse HLA-A2 tumour cells overexpressing the p53 protein. Scand J Immunol (2000) 0.85
Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody. J Virol (1990) 0.85
Complete scanning of the CDK4 gene by denaturing gradient gel electrophoresis: a novel missense mutation but low overall frequency of mutations in sporadic metastatic malignant melanoma. Int J Cancer (1997) 0.85
Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines. Cancer Immunol Immunother (1995) 0.85
Influenza virus-specific murine T cell hybridomas which recognize virus hemagglutinin in conjunction with H-2d and display helper functions for B cells. Curr Top Microbiol Immunol (1982) 0.85
Transfer of tRNAs to somatic cells mediated by Sendai-virus-induced fusion. Proc Natl Acad Sci U S A (1976) 0.84
Tumor infiltrating lymphocytes in melanoma comprise high numbers of T-cell clonotypes that are lost during in vitro culture. Clin Immunol (2000) 0.84
Replication and expression in mammalian cells of transfected DNA; description of an improved erythrocyte ghost fusion technique. Nucleic Acids Res (1983) 0.84
Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. J Natl Cancer Inst (1982) 0.83
Antigen-specific primary immune response of human B-lymphocytes after in vitro immunization with GM3 ganglioside. Hum Antibodies Hybridomas (1995) 0.83
Analysis of T cell receptor alpha beta variability in lymphocytes infiltrating melanoma primary tumours and metastatic lesions. Cancer Immunol Immunother (1994) 0.83
Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma. Leukemia (2000) 0.83
A comparison of flow cytometry and immunohistochemistry in human colorectal cancers. APMIS (1998) 0.82
Characterisation of tumour infiltrating lymphocytes and correlations with immunological surface molecules in colorectal cancer. Eur J Cancer (1999) 0.82
Expression of CD94/NKG2 subtypes on tumor-infiltrating lymphocytes in primary and metastatic melanoma. J Invest Dermatol (2000) 0.82